3-(4-Chloro-2-methylphenoxy)azetidine, 95+%, 2.5g

tert-Butyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8-carboxylate, 97%, 500mg

GC capillary column ROTI®Cap-624, 25 m, 0.32 mm, 1.80 µm, 1 Piece(s)

(R)-TERT-BUTYL 2-ACETYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

(3S)-3-Methylpiperidin-3-ol hydrochloride, 98%, 1g

(4-Bromo-2-(trifluoromethyl)phenyl)methanol, 95.0%, 5g

4-Morpholinophenylboronic acid (contains varying amounts of anhydride), 98.0%, 25g

Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, 98%, 250mg

MC-Val-Ala-PAB-PNP, 100mg

1-Ethylpyrrolidin-3-ol, 97.0%, 25g

6-chloro-3-methyl-2H-pyrazolo[3,4-d]pyrimidine, 97%, 1g

3-acetyl-4-(3,4-difluorophenyl)-6-fluoroquinolin-2(1H)-one, 95.0%, 250mg

2-chloro-4-(1H-tetrazol-5-yl)pyridine, 95.0%, 250mg